Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT02558907
  4. Details
NCT02558907 Clinical Trial

Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology

Cancer Clinical Trial

— MoCA  

Official title:
Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02558907
Other study ID # MoCA
Secondary ID
Status Completed
Phase N/A
First received September 18, 2015
Last updated March 31, 2017
Start date September 2015
Est. completion date March 2017

Study information
Verified date June 2016
Source Centre Francois Baclesse
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Compare neurocognitive testing MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) to candidates aged patients with 1st line treatment of their cancer will be received an examination oncogériatric

Recruitment information / eligibility
Status Completed
Enrollment 66
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender All
Age group 71 Years and older
Eligibility Inclusion Criteria:

- Patient old over 70 years

- Patient with cancer (solid tumor or hematological) for which a 1st line treatment is planned

- Patient candidate an oncogeriatric assessment

- Patient agreeing to participate in the study

- French language

- Lack of subsequent neurological sequelae with cognitive impact stroke, dementia or progressive psychiatric disorder

- Patient having a life expectancy = 6 months

Exclusion Criteria:

- Primitive cancer of the central nervous system or brain metastasis

- Patients unable to meet the cognitive tests

- Refusal to participate

- Realization of a MMSE or MoCA test in the last 6 months

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• cognitive evaluation by MMS (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) tests

Locations
Country Name City State
France Centre François Baclesse Caen
France CHU Caen

Sponsors (1)
Lead Sponsor Collaborator
Centre Francois Baclesse

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary proportion of patients with cognitive disorders identified by the MoCA or the MMSE prior to treatment before their first treatment for the cancer, at inclusion
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients